Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2418568rdf:typepubmed:Citationlld:pubmed
pubmed-article:2418568lifeskim:mentionsumls-concept:C0020295lld:lifeskim
pubmed-article:2418568lifeskim:mentionsumls-concept:C0278314lld:lifeskim
pubmed-article:2418568lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:2418568lifeskim:mentionsumls-concept:C1546466lld:lifeskim
pubmed-article:2418568pubmed:issue6lld:pubmed
pubmed-article:2418568pubmed:dateCreated1986-3-5lld:pubmed
pubmed-article:2418568pubmed:abstractTextA total of 101 patients with hydronephrosis due to tumor obstruction underwent palliative nephrostomies. The average survival was 8.6 months; after 3 months, 32% of the patients were dead. The survival for patients with T3 tumors was 9.3 and for patients with T4 tumors, 6.0 months. The general postoperative health status did not improve in any of the cases. Retrospectively, 42% of the patients did not feel that the nephrostomy had done any good. In 17% of the cases, progressive development of tumor growth was predictable at the time of nephrostomy.lld:pubmed
pubmed-article:2418568pubmed:languagegerlld:pubmed
pubmed-article:2418568pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2418568pubmed:citationSubsetIMlld:pubmed
pubmed-article:2418568pubmed:statusMEDLINElld:pubmed
pubmed-article:2418568pubmed:monthNovlld:pubmed
pubmed-article:2418568pubmed:issn0340-2592lld:pubmed
pubmed-article:2418568pubmed:authorpubmed-author:TauberRRlld:pubmed
pubmed-article:2418568pubmed:authorpubmed-author:ZinkR ARAlld:pubmed
pubmed-article:2418568pubmed:authorpubmed-author:GrootDDlld:pubmed
pubmed-article:2418568pubmed:issnTypePrintlld:pubmed
pubmed-article:2418568pubmed:volume24lld:pubmed
pubmed-article:2418568pubmed:ownerNLMlld:pubmed
pubmed-article:2418568pubmed:authorsCompleteYlld:pubmed
pubmed-article:2418568pubmed:pagination320-2lld:pubmed
pubmed-article:2418568pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:meshHeadingpubmed-meshheading:2418568-...lld:pubmed
pubmed-article:2418568pubmed:year1985lld:pubmed
pubmed-article:2418568pubmed:articleTitle[Therapeutic and ethical problems of nephrostomy in tumor-related hydronephrosis].lld:pubmed
pubmed-article:2418568pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2418568pubmed:publicationTypeEnglish Abstractlld:pubmed